Guang-Bo Ge

InstitutionShanghai University of Traditional Chinese Medicine
AddressShanghai
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 9 Covid-19 publications, with a maximum of 3 publications in April 2021
    All Publications
    Bar chart showing 152 publications over 15 distinct years, with a maximum of 22 publications in 2015
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Xu X, Xia J, Zhao S, Wang Q, Ge G, Xu F, Liu X, Zhang W, Yang Y. Qing-Fei-Pai-Du decoction and wogonoside exert anti-inflammatory action through down-regulating USP14 to promote the degradation of activating transcription factor 2. FASEB J. 2021 09; 35(9):e21870. PMID: 34436790.
      Fields:    Translation:AnimalsCells
    2. Xiong Y, Zhu GH, Zhang YN, Hu Q, Wang HN, Yu HN, Qin XY, Guan XQ, Xiang YW, Tang H, Ge GB. Flavonoids in Ampelopsis grossedentata as covalent inhibitors of SARS-CoV-2 3CLpro: Inhibition potentials, covalent binding sites and inhibitory mechanisms. Int J Biol Macromol. 2021 Sep 30; 187:976-987. PMID: 34333006.
      Citations: 2   Article has an altmetric score of 4    Fields:    Translation:AnimalsCells
    3. Zhang F, Liu W, Huang J, Chen QL, Wang DD, Zou LW, Zhao YF, Zhang WD, Xu JG, Chen HZ, Ge GB. Inhibition of drug-metabolizing enzymes by Jingyin granules: implications of herb-drug interactions in antiviral therapy. Acta Pharmacol Sin. 2021 Jun 28. PMID: 34183756.
      Citations: 1   Article has an altmetric score of 1    Fields:    
    4. Wang R, Hu Q, Wang H, Zhu G, Wang M, Zhang Q, Zhao Y, Li C, Zhang Y, Ge G, Chen H, Chen L. Identification of Vitamin K3 and its analogues as covalent inhibitors of SARS-CoV-2 3CLpro. Int J Biol Macromol. 2021 Jul 31; 183:182-192. PMID: 33901557.
      Citations: Article has an altmetric score of 8    Fields:    Translation:Humans
    5. Xiong Y, Zhu GH, Wang HN, Hu Q, Chen LL, Guan XQ, Li HL, Chen HZ, Tang H, Ge GB. Discovery of naturally occurring inhibitors against SARS-CoV-2 3CLpro from Ginkgo biloba leaves via large-scale screening. Fitoterapia. 2021 Jul; 152:104909. PMID: 33894315.
      Citations: 4   Article has an altmetric score of 67    Fields:    Translation:HumansAnimalsCells
    6. Liu W, Huang J, Zhang F, Zhang CC, Li RS, Wang YL, Wang CR, Liang XM, Zhang WD, Yang L, Liu P, Ge GB. Comprehensive profiling and characterization of the absorbed components and metabolites in mice serum and tissues following oral administration of Qing-Fei-Pai-Du decoction by UHPLC-Q-Exactive-Orbitrap HRMS. Chin J Nat Med. 2021 Apr; 19(4):305-320. PMID: 33875170.
      Citations: 4   Fields:    Translation:Animals
    7. Zhang F, Huang J, Liu W, Wang CR, Liu YF, Tu DZ, Liang XM, Yang L, Zhang WD, Chen HZ, Ge GB. Inhibition of drug-metabolizing enzymes by Qingfei Paidu decoction: Implication of herb-drug interactions in COVID-19 pharmacotherapy. Food Chem Toxicol. 2021 Mar; 149:111998. PMID: 33476691.
      Citations: 7   Fields:    Translation:AnimalsCells
    8. Zhao J, Tian S, Lu D, Yang J, Zeng H, Zhang F, Tu D, Ge G, Zheng Y, Shi T, Xu X, Zhao S, Yang Y, Zhang W. Systems pharmacological study illustrates the immune regulation, anti-infection, anti-inflammation, and multi-organ protection mechanism of Qing-Fei-Pai-Du decoction in the treatment of COVID-19. Phytomedicine. 2021 May; 85:153315. PMID: 32978039.
      Citations: 19   Article has an altmetric score of 3    Fields:    Translation:HumansAnimalsCells
    9. Wu GS, Zhong J, Zheng NN, Wang CR, Jin HL, Ge GB, Han JY, Gao Y, Sheng LL, Zhang WD, Li HK. [Investigation of modulating effect of Qingfei Paidu Decoction on host metabolism and gut microbiome in rats]. Zhongguo Zhong Yao Za Zhi. 2020 Aug; 45(15):3726-3739. PMID: 32893565.
      Citations: 3   Article has an altmetric score of 1    Fields:    Translation:AnimalsCells